Qing Xi Ooi supports clients with hands-on analysis and strategic advice

Viviana Moroso brings scientific depth to quality control

Siv Jönsson develops Pharmetheus’s learning agenda
Events
News

Contact us

Home
Publications

Publications

Below we provide links to posters, white papers and scientific publications by Pharmetheus affiliates in chronological order. Please note that access to some publications may require a subscription.

Search publications

Publications

21.11.25

Exposure-Efficacy Meta-model of Nintedanib in Adult Patients with Chronic Fibrosing Interstitial Lung Diseases

MIDD

Regulatory interactions

Specific populations

Pharmacometrics

Respiratory

Program strategies and efficiencies

Methodology

CPT Pharmacometrics Syst Pharmacol. 2025 Nov 21. Online ahead of print.

Hartman S, Janssen J, Ribbing J, Stowasser S, Korell J

20.11.25

Exposure-response analysis for time-to-event data in the presence of adaptive dosing: efficient approaches and pitfalls

MIDD

Trial design and analysis

Methodology

CPT Pharmacometrics Syst Pharmacol. 2025 Nov 20. Online ahead of print.

Lavalley-Morelle A, Le Louedec F, Anziano RJ, Mentré F, Bergstrand M

18.11.25

Dose Modifications in Exposure-Response Analyses of Oncology Drug Development: Brigimadlin Case Study

Oncology

PBPK & PBBM

MIDD

Pharmacometrics

Methodology

ACoP16 (Oct 2025), Poster: M-115

Le Louedec F, Kang J, Sarr C, Neldemo I, Wiens M, Baron K, Lamar M, Pérez-Pitarch A, Schmid U, Sailer R, Bergstrand M, Busse D

18.11.25

Exposure-Overall Survival Analysis for Quizartinib in Newly Diagnosed Patients with FMS- Like Tyrosine Kinase 3-Internal-Tandem-Duplication-Positive Acute Myeloid Leukemia

Oncology

Pharmacometrics

Program strategies and efficiencies

ACoP16 (Oct 2025), Poster: S-075

Smania G, Glatard A, Vaddady P, Nakayama S, Inoue H, Mezzalana E, Simonsson USH, Abutarif M, Zheng M

18.11.25

Simplifying the Communication of Covariate Effects from Pharmacometric Models – The Role of Unconditional Covariate Effects

MIDD

Pharmacometrics

Methodology

ACoP16 (Oct 2025), Poster: T-069

Jonsson EN, Jönsson S, Hansson E, Nyberg J

28.10.25

The evolving role of in vitro - in vivo correlation in Model-Informed Drug Development: A multi-stakeholder perspective

PBPK & PBBM

MIDD

Regulatory interactions

Pharmacometrics

Program strategies and efficiencies

CPT Pharmacometrics Syst Pharmacol. 2025 Oct 28. Online ahead of print.

Chenel M, Fouliard S, Hansson E, Brendel K, Jacobs M, Lennernäs H, Sjögren E, Bergstrand M

16.10.25

Model-Informed Drug Development in Small Populations

MIDD

Specific populations

Genetic

EFGCP Better Medicines for Children Conference 2025

Hansson E

15.10.25

Regulatory Aspects of Sex-Related Differences in Drug Development: Past, Present, and Future

MIDD

Specific populations

Oral Presentation: GMP 37th Symposium

Hansson E

1 …567… 34

Related content

16cefda6ef73b7faa4df913b326b6999f7619968 (1)

Science & Services

b794ade33e3aa54f89dcdaa2b69d3f48b3f73e5f (1)

Latest news

4033665f49ccf946b5c8406d016bbcdc6e406076 (1)

People & Culture

Contact

Pharmetheus AB
Kungsängstull 4  
753 19 Uppsala, Sweden

Visiting address:  
Dragarbrunnsgatan 77, 5th floor

LinkedIn
YouTube

Science & Services
Quick links

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Copyright © Pharmetheus AB 2026

Whistleblower
Privacy Policy
Cookie Policy